Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer.

NCT01514565 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT01514565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01514565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer.
Lead sponsor
Thomas Jefferson University
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2011
Completion date
December 31, 2018
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer